Erythromycin

FDA

• Preoperative bowel preparation (with neomycin)
• Syphilis caused by Treponema pallidum (in patients allergic to the penicillins, but azithromycin preferred)
• Acute exacerbations of chronic bronchitis and sinusitis
• Acute otitis media and pharyngitis
• Diphtheria infections due to Corynebacterium diphtheriae, as an adjunct to antitoxin
• Intestinal amebiasis caused by Entamoeba histolytica
• Conjunctivitis in the newborn caused by Chlamydia trachomatis
• Legionnaires disease
• Pertussis
• Rheumatic fever prophylaxis
• Upper respiratory tract infections caused by Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae (when used concomitantly with adequate sulfonamide dosage),
• Labeled pathogens:
  • Lower respiratory tract infections caused by Mycoplasma pneumonia, Streptococcus pyogenes or S. pneumonia
  • Llisteriosis
  • Skin and soft tissue infections
  • Erythrasma
  • Acute inflammatory pelvic disease, uncomplicated urethral, endocervical, or rectal infections caused by Chlamydia trachomatis
• Ophthalmic formulation:
  
  • Blepharitis
  • Conjunctivitis
  • Prophylaxis of ophthalmia neonatorum due to N. gonorrhoeae or C. trachomatis